BN Immunotherapeutics, Inc.

Organization

Washington, DC, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Use of MVA to treat prostate cancer
- Patent number 8,377,688
- Issue date Feb 19, 2013
- BN Immunotherapeutics, Inc.
- Alain Delcayre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating cancer with a recombinant MVA expressing HER-2
- Patent number 8,313,740
- Issue date Nov 20, 2012
- BN Immunotherapeutics, Inc.
- Alain Delcayre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunogenic HER-2 variants
- Patent number 8,022,039
- Issue date Sep 20, 2011
- BN Immunotherapeutics, Inc.
- Marie Eskling
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of MVA to treat prostate cancer
- Patent number 7,867,483
- Issue date Jan 11, 2011
- BN Immunotherapeutics, Inc.
- Alain Delcayre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for therapeutic vaccination
- Patent number 7,820,633
- Issue date Oct 26, 2010
- BN Immunotherapeutics, Inc.
- Lucilla Steinaa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating cancer with a recombinant MVA expressing HER-2
- Patent number 7,807,146
- Issue date Oct 5, 2010
- BN Immunotherapeutics, Inc.
- Alain Delcayre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for therapeutic vaccination
- Patent number 7,807,441
- Issue date Oct 5, 2010
- BN Immunotherapeutics, Inc.
- Lucilla Steinaa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purification of HER-2 variants
- Patent number 7,763,452
- Issue date Jul 27, 2010
- BN Immunotherapeutics, Inc.
- Marie Eskling
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
77577729 - PROSTVAC
- Serial number 77577729
- Registration number 3873966
- Filing date Sep 24, 2008
- BN ImmunoTherapeutics Inc.
- 5 - Pharmaceutical and veterinary preparations

BN Immunotherapeutics, Inc.

Organization

Patents Grantslast 30 patents

Use of MVA to treat prostate cancer

Methods for treating cancer with a recombinant MVA expressing HER-2

Immunogenic HER-2 variants

Use of MVA to treat prostate cancer

Methods for therapeutic vaccination

Methods for treating cancer with a recombinant MVA expressing HER-2

Methods for therapeutic vaccination

Purification of HER-2 variants

Trademarklast 30 trademarks

77577729 - PROSTVAC